Home › NDC Lookup › RxCUI directory › RxCUI 721795

24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel] — RxCUI 721795

RxNorm drug concept · Semantic branded drug
RxCUI 721795 Semantic branded drug · SBD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI721795
Official name24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR Seroquel 300 MG Extended Release Oral Tablet; SEROQUEL XR 300 MG 24HR Extended Release Oral Tablet; Seroquel XR 300 MG (quetiapine fumarate 345 MG) 24 HR Extended Release Oral Tablet
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)828 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Quetiapine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Quetiapine is approved to treat schizophrenia, bipolar disorder (both manic episodes and depressive episodes), and — in the extended-release form only — as an add-on to an antidepr...
  • It depends on the form. If you're taking the regular tablet, you can take it with or without food — no restrictions. But if you're on the extended-release tablet, you should take i...
  • Does it matter if I take quetiapine with food?
  • Sleepiness is actually one of the most common side effects — in some studies, more than half of patients reported it. Quetiapine blocks histamine receptors in the brain, which has...
📖 Read our full Quetiapine guide →

🕸️ Concept Web — How 24 HR quetiapine 300 MG Extended Release Oral Ta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel] RxCUI 721795

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Quetiapine 51272
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Seroquel 83553
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Quetiapine Extended Release Oral Tablet 721790
    • Quetiapine Oral Product 1157343
    • Quetiapine Pill 1157344
    • Quetiapine Extended Release Oral Tablet [Seroquel] 721792
    • Seroquel Oral Product 1180762
    • Seroquel Pill 1180763
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit] 1648647
    • {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet) } Pack 1648646

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR quetiapine 300 MG Extended Release Oral Tablet SCD · 721794
  • Quetiapine 300 MG SCDC · 331545
  • Quetiapine Extended Release Oral Tablet SCDF · 721790
  • Quetiapine Oral Product SCDG · 1157343
  • Quetiapine Pill SCDG · 1157344
  • {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet) } Pack GPCK · 1648646

Brand-Name Concepts

  • Quetiapine 300 MG [Seroquel] SBDC · 574938
  • Quetiapine Extended Release Oral Tablet [Seroquel] SBDF · 721792
  • Seroquel Oral Product SBDG · 1180762
  • Seroquel Pill SBDG · 1180763
  • Seroquel BN · 83553
  • {1 (24 HR quetiapine 200 MG Extended Release Oral Tablet [Seroquel]) / 11 (24 HR quetiapine 300 MG Extended Release Oral Tablet [Seroquel]) / 3 (24 HR quetiapine 50 MG Extended Release Oral Tablet [Seroquel]) } Pack [Seroquel XR 14-Day Sample Kit] BPCK · 1648647

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 721795 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00310-0281-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0281-60) SEROQUEL XR AstraZeneca Pharmaceuticals LP 2009-02-01
00310-0282-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-60) SEROQUEL XR AstraZeneca Pharmaceuticals LP 2007-07-16
00310-0283-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0283-60) SEROQUEL XR AstraZeneca Pharmaceuticals LP 2007-07-16
00310-0284-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0284-60) SEROQUEL XR AstraZeneca Pharmaceuticals LP 2007-07-16
61269-0270-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-270-60) SEROQUEL XR H2-Pharma, LLC 2009-02-01
61269-0271-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-271-60) SEROQUEL XR H2-Pharma, LLC 2009-02-01
61269-0272-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-272-60) SEROQUEL XR H2-Pharma, LLC 2007-07-16
61269-0273-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-273-60) SEROQUEL XR H2-Pharma, LLC 2007-07-16
61269-0274-60 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (61269-274-60) SEROQUEL XR H2-Pharma, LLC 2007-07-16
Observed labelers: H2-Pharma, LLC (5) · AstraZeneca Pharmaceuticals LP (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.